KA
CC icon

Kaizen Advisory’s Chemours CC Stock Holding History

Kaizen Advisory’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$565K Sell
20,042
-3,814
-16% -$121K 0.39% 103
2018
Q3 		$941K Buy
+23,856
New +$1.04M 0.49% 93

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Kaizen Advisory's CC Position: Q4 2018 in Review

Kaizen Advisory reduced its Chemours (CC) stake by 16% in Q4 2018, selling an estimated $121K and leaving 20,042 shares worth $565K. The position accounts for 0.39% of the portfolio, ranked #103.

Kaizen Advisory first reported a position in CC in Q3 2018 and has held it in 2 quarters since. The position peaked at $941K in Q3 2018. 506 funds tracked by Wall St. Rank hold CC as of Q4 2018.

  • Kaizen Advisory held 20,042 shares of Chemours worth $565K as of Q4 2018.
  • Kaizen Advisory sold 3,814 Chemours shares in Q4 2018, an estimated $121K.
  • Chemours made up 0.39% of Kaizen Advisory's portfolio in Q4 2018, its #103 holding.
  • Kaizen Advisory first reported a position in Chemours in Q3 2018 and has held it in 2 quarters since.
  • Kaizen Advisory's Chemours position peaked at $941K in Q3 2018.
  • 506 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.